US Pays Eli Lilly $375M for 300,000 COVID-19 Vaccine Doses

The U.S. government will pay Eli Lilly $375 million to supply 300,00 doses of its experimental antibody drug to treat the coronavirus, the company announced Wednesday.

The agreement is for delivery over the two months following an emergency use authorization from the Food and Drug Administration. The deal also provides the option for the U.S. government to purchase 650,000 more doses through June 30, the company said.

“Lilly has leveraged our deep scientific capability to fight this pandemic and we are proud of our efforts to develop potential medicines to combat COVID-19,” Eli Lilly’s CEO David Ricks said in a statement.

Read the source article at cnbc.com

Leave a Review or Comment

Back to top button